JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haubrich, D. R.
Right arrow Articles by Wedeking, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haubrich, D. R.
Right arrow Articles by Wedeking, P. W.

Distribution and metabolism of intravenously administered choline[methyl- 3-H] and synthesis in vivo of acetylcholine in various tissues of guinea pigs

DR Haubrich, PF Wang and PW Wedeking

The biosynthesis of acetylcholine and the fate of intravenously administered choline [methyl- 3-H] were studied in guinea pigs anesthetized with pentobarbital. Choline and acetylcholine were isolated by paper electrophoresis and estimated by use of a specific enzymatic (choline kinase) - radioisotopic assay. The concentration of acetylcholine ranged from 25.5 to 1.1 nmol/g in the following tissues (in order of decreasing concentration): duodenum, corpus striatum, stomach, cerebral cortex, spinal cord, abdominal fat, submaxillary gland, kidney, adrenal gland, spleen, liver, lung, heart and diaphragm. Choline [methyl- 3-H] was converted in the tissues to acetylcholine within 3 minutes after intravenous administration of the precursor. Virtually all the radioactivity in plasma at that time was present as free choline, suggesting that free choline from plasma is the immediate precursor for acetylcholine synthesized in the tissues cited. The concentration of free choline in tissues ranged from 344 nmol/g in adrenals to 40 nmol/g in heart, while that in plasma was 15 nmol/g. The initial half-life of choline in plasma, estimated from the rate of disappearance of choline after intravenous administration of either a tracer dose of choline [methyl- 3-H] (0.031 mumol/kg) or a high dose of choline chloride (200 mumol/kg), was less than 1 minute. This rapid removal of choline from plasma resulted from uptake (or binding) by tissues, with kidney and liver removing about 50% of the administered dose of choline [methyl- 3-H] within 3 minutes after its administration. Uptake of choline occurred in all tissues cited above, but there was a 20-fold difference in the uptake by the most active tissues (kidney and adrenals), as compared to that of the least active (central nervous system). Within 60 minutes after administration of choline [methyl- 3-H], most of the radioactive choline taken up by tissues had been converted to organic-soluble metabolites and to water- soluble metabolites that behaved like either phosphorylcholine or betaine during paper electrophoresis and chromatography. Betaine was the principal metabolite of choline in plasma. Radioactivity was excreted slowly into urine, which contained primarily free choline, betaine and a large amount of an unidentified metabolite. These findings indicate that the principal mechanism for the rapid removal of choline from plasma is uptake into tissues followed by metabolism.

Volume 193, Issue 1, pp. 246-255, 04/01/1975
Copyright © 1975 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
W. Bernhard, C. J. Pynn, A. Jaworski, G. A. Rau, J. M. Hohlfeld, J. Freihorst, C. F. Poets, D. Stoll, and A. D. Postle
Mass Spectrometric Analysis of Surfactant Metabolism in Human Volunteers Using Deuteriated Choline
Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 54 - 58.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. R. DeGrado, R. E. Reiman, D. T. Price, S. Wang, and R. E. Coleman
Pharmacokinetics and Radiation Dosimetry of 18F-Fluorocholine
J. Nucl. Med., January 1, 2002; 43(1): 92 - 96.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. R. DeGrado, R. E. Coleman, S. Wang, S. W. Baldwin, M. D. Orr, C. N. Robertson, T. J. Polascik, and D. T. Price
Synthesis and Evaluation of 18F-labeled Choline as an Oncologic Tracer for Positron Emission Tomography: Initial Findings in Prostate Cancer
Cancer Res., January 1, 2000; 61(1): 110 - 117.
[Abstract] [Full Text]


Home page
J. Am. Coll. Nutr.Home page
A. L. Buchman, D. Jenden, and M. Roch
Plasma Free, Phospholipid-Bound and Urinary Free Choline All Decrease During a Marathon Run and May Be Associated with Impaired Performance
J. Am. Coll. Nutr., December 1, 1999; 18(6): 598 - 601.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Bartus, R. Dean, J. Goas, and A. Lippa
Age-related changes in passive avoidance retention: modulation with dietary choline
Science, July 11, 1980; 209(4453): 301 - 303.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics.